Current and Future Perspectives on the COVID-19 Vaccine: A Scientometric Review

Noruzi, Alireza and Gholampour, Behzad and Gholampour, Sajad and Jafari, Somayeh and Farshid, Razieh and Stanek, Agata and Saboury, Ali Akbar Current and Future Perspectives on the COVID-19 Vaccine: A Scientometric Review. Journal of Clinical Medicine, 2022, vol. 11, n. 3, pp. 1-21. [Journal article (Paginated)]

[img]
Preview
 Text
COVID-19-Vaccine.pdf
Download (5MB) | Preview

English abstract

This study attempted to draw the present and future perspective of the COVID-19 vaccine by identifying the most important scientists and their scientific contexts, trends of research topics, and relationships between different entities. Methods: To achieve this purpose, bibliometric and scientometric techniques were used to analyze 6288 scientific documents contributing to COVID-19 vaccines from the beginning of 2019 to 13 December 2021, indexed in the Web of Science. Results: The United States (US) had the greatest impact by publishing 2104 documents and receiving 32,958 citations. The US and the UK countries had the highest level of scientific collaborations with 192 collaborative studies. The University of Oxford and the Harvard Medical School were the most active institutions, and the University of Oxford and Emory University were the most influential institutions. Pollard AJ and Lambe T had the most publications and the highest citations and h-index. T Lambe, SC Gilbert, M Voysey, and AJ Pollard from the University of Oxford had the highest number of co-authorships. More than 19% of the research was conducted in the field of immunology. The Vaccines journal had the most publications, with 425 articles. The US Department of Health & Human Services granted the most research. In 2019, studies were focused on the topics of COVID-19 virus identification and ways to deal with it; in 2020, studies focused on the topics of COVID-19 and vaccines, whereas in 2021, they focused on the topics of COVID-19 vaccines and their effects, vaccines hesitancy, the role of healthcare workers in COVID-19, as well as discussions about these vaccines in the social media. Conclusions: Recognition of the most important actors (countries, institutes, researchers, and channels for the release of COVID-19 vaccine studies), research trends, and fields of study on the COVID-19 vaccine can be useful for researchers, countries, and policy makers in the field of science and health to make decisions and better understand these vaccines.

Item type: Journal article (Paginated)
Keywords: COVID-19 vaccine; COVID-19 vaccination; bibliometric analysis; research trends; research topics; scientific collaboration
Subjects: B. Information use and sociology of information > BB. Bibliometric methods
Depositing user: Dr. Alireza Noruzi
Date deposited: 30 Jan 2022 06:40
Last modified: 30 Jan 2022 06:40
URI: http://hdl.handle.net/10760/42865

References

1. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses 2020;12:135. https://doi.org/10.3390/V12020135

2. Chen Y, Cheng L, Lian R, Song Z, Tian J. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer. Biosci Trends 2021;15:64–73. https://doi.org/10.5582/BST.2021.01061

3. Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA, Martinez JA, et al. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 2020;18:1–7. https://doi.org/10.1186/S12967-020-02364-2

4. Moradian N, Moallemian M, Delavari F, Sedikides C, Camargo CA, Torres PJ, et al. Interdisciplinary Approaches to COVID-19. Adv Exp Med Biol 2021;1318:923–36. https://doi.org/10.1007/978-3-030-63761-3-52

5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

6. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475–81. https://doi.org/10.1016/S2213-2600(20)30079-5

7. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13. https://doi.org/10.1016/S0140-6736(20)30211-7

8. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269–71. https://doi.org/10.1038/S41422-020-0282-0

9. WHO. Coronavirus (COVID-19) Dashboard. World Heal Organ 2021. https://covid19.who.int/.

10. Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-Rivera OA, et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 2020 158 2020;15:646–55. https://doi.org/10.1038/s41565-020-0737-y

11. Haber P, Amin M, Ng C, Weintraub E, McNeil MM. Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016. Hum Vaccines Immunother 2018;14:2755–9. https://doi.org/10.1080/21645515.2018.1491509

12. US Food & Drug Administration. Comirnaty and Pfizer-BioNTech COVID-19 Vaccine | FDA 2020. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine#additional

13. Graham BS. Rapid COVID-19 vaccine development. Science (80- ) 2020;368:945–6. https://doi.org/10.1126/SCIENCE.ABB8923

14. Zhang Y, Quan L, Xiao B, Du L. The 100 top-cited studies on vaccine: a bibliometric analysis. Hum Vaccin Immunother 2019;15:3024–31. https://doi.org/10.1080/21645515.2019.1614398

15. Zimmer C, Corum J, Wee S-L. Covid-19 Vaccine Tracker. New York Times 2020. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html?searchResultPosition=1

16. Hasan A, Paray BA, Hussain A, Qadir FA, Attar F, Aziz FM, et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn 2020;39:3025–33. https://doi.org/10.1080/07391102.2020.1754293

17. Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, et al. Infection of human cells by SARS CoV-2 and molecular overview on gastrointestinal, neurological and hepatic problems in COVID-19 patients. J Clin Med 2021;10:4082. https://doi.org/https://doi.org/10.3390/jcm10214802

18. Ay MO, Erenler AK, Ay OO, Kaya H, Yuksel M, Kekec Z. A scientometric analysis of COVID-19 vaccine publications. World J Adv Res Rev 2021;9:138–47. https://doi.org/10.30574/WJARR.2021.9.3.0093

19. Jafari SB, Farshid R. Studying of Research Related to COVID-19 Vaccine in Iran and the World: A Thematic Analysis and Scientific Collaborations - Iranian Journal of Medical Microbiology. Iran J Med Microbiol 2021;15:5–5. https://doi.org/http://ijmm.ir/article-1-1328-en.html

20. Gholampour S, Noruzi A, Gholampour B, Elahi A. Research Trends and Bibliometric Analysis of a Journal: Sport Management Review. Webology 2019;16:223–41. https://doi.org/10.14704/WEB/V16I2/a200

21. Gholampour B, Gholampour S, Noruzi A. Highly Cited Papers in Sport Sciences: Identification and Conceptual Analysis. Int J Inf Sci Manag 2022;xx: forthcoming.

22. Gholampour B, Gholampour S, Noruzi A, Arsenault C, Haertlé T, Saboury AA. Retracted Articles in Oncology in the Last three Decades: Frequency, Reasons and Themes. Scientometrics 2022;xx: forthcoming.

23. Gholampour B, Saboury AA, Noruzi A. Visualizing Hot and Emerging Topics in Biochemistry and Molecular Biology in Iran. Iran J Inf Process Manag 2020;35:1119–48. https://doi.org/http://jipm.irandoc.ac.ir/article-1-4306-en.html

24. Surulinathi M, Arputha Sahaya Rani Y, Srinivasaragavan S, Jayasuriya T. Research output on Covid-19/Coronavirus Vaccine: A Scientometric Study. Libr Philos Pract 2020:4781. https://doi.org/https://digitalcommons.unl.edu/libphilprac/4781


Downloads

Downloads per month over past year

Actions (login required)

View Item View Item
Contact us
Send email Sponsors
Sponsor: AIMS Sponsor: D&P Sponsor: UniNa CAB Get connected
Facebook Facebook Twitter Twitter Linkedin LinkedIn RSS RSS